AN

Awakash Namdeorao Khaire

Active Director Director DIN 08027493
DIN 08027493 First appointment Jan 2018 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2018
Shareholding value •••• Premium profile

About Awakash Namdeorao Khaire

Data last updated:

Awakash Namdeorao Khaire is a Director at Aerolite Pharmaceuticals Private Limited (since 2018). The company operates in Business Services. Aerolite Pharmaceuticals Private Limited reported revenue of ₹31.5 Lakh (FY 2025).

DIN 08027493
Primary Designation Director
Industry Business Services
First Appointment 16 Jan 2018
Oldest Company Age 8 yrs
Largest company Aerolite Pharmaceuticals Private Limited · ₹31.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Jan 20182018₹31.5 Lakh (FY 2025)Active

Board colleagues of Awakash Namdeorao Khaire

Directorship timeline

Open interactive timeline →
Aerolite Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Awakash Namdeorao Khaire

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Awakash Namdeorao Khaire

Awakash Namdeorao Khaire currently holds 1 directorship: Aerolite Pharmaceuticals Private Limited (Director, since 16 Jan 2018, revenue ₹31.5 Lakh (FY 2025)).

Awakash Namdeorao Khaire was first appointed on 16 Jan 2018 as Director at Aerolite Pharmaceuticals Private Limited.

The current boards of Awakash Namdeorao Khaire's companies include Bhausaheb Vasant Hingane (Aerolite Pharmaceuticals Private Limited), Sushil Kumar Waghmare (Aerolite Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available